These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 26769660)
1. Association between alcohol consumption and serum paraoxonase and arylesterase activities: a cross-sectional study within the Bavarian population. Schwedhelm C; Nimptsch K; Bub A; Pischon T; Linseisen J Br J Nutr; 2016 Feb; 115(4):730-6. PubMed ID: 26769660 [TBL] [Abstract][Full Text] [Related]
2. Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study. Meisinger C; Freuer D; Bub A; Linseisen J Lipids Health Dis; 2021 Jul; 20(1):81. PubMed ID: 34332593 [TBL] [Abstract][Full Text] [Related]
3. Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B. Mogarekar MR; Talekar SJ Indian J Gastroenterol; 2013 Sep; 32(5):307-10. PubMed ID: 23700138 [TBL] [Abstract][Full Text] [Related]
4. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia. Aslan M; Kosecik M; Horoz M; Selek S; Celik H; Erel O Atherosclerosis; 2007 Apr; 191(2):397-402. PubMed ID: 16684543 [TBL] [Abstract][Full Text] [Related]
5. Postprandial Paraoxonase 1 Activity Following Consumption of Recommended Amounts of Mixed Meals in Healthy Males. Kameyama N; Maruyama C; Kotani K; Caccavello R; Gugliucci A; Matsui S; Araki R; Maruyama T J Atheroscler Thromb; 2016; 23(2):225-32. PubMed ID: 26447089 [TBL] [Abstract][Full Text] [Related]
6. Paraoxonase-1 (PON1) activity as a risk factor for atherosclerosis in chronic renal failure patients. Saeed SA; Elsharkawy M; Elsaeed K; Fooda O Hemodial Int; 2008 Oct; 12(4):471-9. PubMed ID: 19090870 [TBL] [Abstract][Full Text] [Related]
7. Oxidative status and serum PON1 activity in beta-thalassemia minor. Selek S; Aslan M; Horoz M; Gur M; Erel O Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173 [TBL] [Abstract][Full Text] [Related]
8. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins. Miyamoto T; Takahashi Y; Oohashi T; Sato K; Oikawa S J Vet Med Sci; 2005 Mar; 67(3):243-8. PubMed ID: 15805725 [TBL] [Abstract][Full Text] [Related]
10. Oxidant and antioxidant of arylesterase and paraoxonase as biomarkers in patients with hepatitis C virus. Ali EM; Shehata HH; Ali-Labib R; Esmail Zahra LM Clin Biochem; 2009 Sep; 42(13-14):1394-400. PubMed ID: 19538950 [TBL] [Abstract][Full Text] [Related]
11. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS. Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314 [TBL] [Abstract][Full Text] [Related]
12. Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: correlation with susceptibility of LDL oxidation. Mehdi MM; Rizvi SI Arch Med Res; 2012 Aug; 43(6):438-43. PubMed ID: 22959975 [TBL] [Abstract][Full Text] [Related]
13. Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women. Cervellati C; Bonaccorsi G; Trentini A; Valacchi G; Sanz JM; Squerzanti M; Spagnolo M; Massari L; Crivellari I; Greco P; Parladori R; Passaro A; Ricci G Scand J Clin Lab Invest; 2018; 78(1-2):18-24. PubMed ID: 29168398 [TBL] [Abstract][Full Text] [Related]
14. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population. Elkiran ET; Mar N; Aygen B; Gursu F; Karaoglu A; Koca S BMC Cancer; 2007 Mar; 7():48. PubMed ID: 17362500 [TBL] [Abstract][Full Text] [Related]
15. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation. Serhatlioglu S; Gursu MF; Gulcu F; Canatan H; Godekmerdan A Cell Biochem Funct; 2003 Dec; 21(4):371-5. PubMed ID: 14624476 [TBL] [Abstract][Full Text] [Related]
16. Decreased serum paraoxonase and arylesterase activities in patients with rosacea. Takci Z; Bilgili SG; Karadag AS; Kucukoglu ME; Selek S; Aslan M J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):367-370. PubMed ID: 24854673 [TBL] [Abstract][Full Text] [Related]
17. Correlation of High-Density Lipoprotein-Associated Paraoxonase 1 Activity With Systemic Inflammation, Disease Activity, and Cardiovascular Risk Factors in Psoriatic Disease. Husni ME; Wilson Tang WH; Lucke M; Chandrasekharan UM; Brennan DM; Hazen SL Arthritis Rheumatol; 2018 Aug; 70(8):1240-1250. PubMed ID: 29569857 [TBL] [Abstract][Full Text] [Related]
18. Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity. Keskin M; Dolar E; Dirican M; Kiyici M; Yilmaz Y; Gurel S; Nak SG; Erdinc S; Gulten M Intern Med J; 2009 Apr; 39(4):243-8. PubMed ID: 19402863 [TBL] [Abstract][Full Text] [Related]
19. PON1 status in haemodialysis patients and the impact of hepatitis C infection. Horoz M; Aslan M; Selek S; Koylu AO; Bolukbas C; Bolukbas FF; Celik H; Erel O Clin Biochem; 2007 Jun; 40(9-10):609-14. PubMed ID: 17335792 [TBL] [Abstract][Full Text] [Related]
20. Paraoxonase 1 activities and genetic variation in childhood obesity. Rupérez AI; López-Guarnido O; Gil F; Olza J; Gil-Campos M; Leis R; Tojo R; Cañete R; Gil A; Aguilera CM Br J Nutr; 2013 Nov; 110(9):1639-47. PubMed ID: 23789921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]